查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594685

光學臨床前影像市場：按產品類型、最終用途分類 - 2025-2030 年全球預測

Optical Preclinical Imaging Market by Product Type (Consumables, Device, Software), End-Use (Pharma & Biotech Companies, Research Institutes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

光學臨床前影像市場2023年估值為13.2億美元，預計到2024年將達到15.1億美元，複合年成長率為14.39%，預計到2030年將達到33.9億美元。

光學臨床前影像市場包括用於實驗室研究階段的非侵入性視覺化，以監測活體動物（主要是囓齒動物）的疾病進展、藥物療效和生物過程。這個利基市場對於轉化研究是必要的，動物模型的見解有助於理解和治療人類疾病，並且對於藥物開發和生物醫學至關重要。應用範圍廣泛，包括腫瘤學、神經病學、心臟病學和幹細胞研究，其使用在學術機構、製藥和生物技術領域的臨床前環境中至關重要。主要成長動力包括螢光和生物發光等成像技術的技術進步，這些技術提高了解析度和靈敏度。慢性病發病率的上升、研發成本的上升以及人類和動物測試的更道德替代方案的推廣是市場擴張的進一步驅動力。新的機會包括整合人工智慧以增強影像分析、小型化以及開發多模態成像系統以提供跨生物系統的全面見解。然而，該市場面臨設備成本高、監管環境複雜以及對技術人員的需求等限制，為新進入者設置了障礙。遵守不斷發展的道德標準並檢驗準確模擬人類疾病的動物模型仍然是一個挑戰。未來的創新可以集中在減少成像技術的侵入性和成本並擴大其可用性。鼓勵企業投資與學術研究機構的合作夥伴關係，以利用尖端技術並在研究基礎設施不斷發展的新興地區尋求市場。光學臨床前成像市場的本質是動態的，受到快速技術創新以及與各個生命科學領域的緊密聯繫的推動。

主要市場統計
基準年[2023] 13.2億美元
預測年份 [2024] 15.1億美元
預測年份 [2030] 33.9億美元
複合年成長率（%） 14.39%

市場動態：揭示快速發展的光學臨床前成像市場的關鍵市場洞察

供需的動態交互作用正在改變光學臨床前成像市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 臨床前影像在各領域的使用增加
    • 臨床研究組織 (CRO) 和製藥公司的增加
    • 增加在生命科學和化妝品領域的應用
  • 市場限制因素
    • 安裝和營運成本高
  • 市場機會
    • 分子成像技術的進展
    • 增加官民合作關係資金籌措以支持臨床前研究
  • 市場問題
    • 嚴格的法律規範

波特五力：駕馭光學臨床前影像市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解光學臨床前影像市場的外部影響

外部宏觀環境因素在塑造光學臨床前成像市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解光學臨床前影像市場的競爭格局

對光學臨床前成像市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣：光學臨床前影像市場供應商的績效評估

FPNV定位矩陣是評估光學臨床前影像市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃光學臨床前影像市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，光學臨床前成像市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 臨床前影像在各領域的使用增加
      • 臨床研究組織 (CRO) 和製藥公司的增加
      • 增加在生命科學和化妝品領域的應用
    • 抑制因素
      • 安裝和營運成本高
    • 機會
      • 分子影像技術進步
      • 增加官民合作關係的資金以支持臨床前研究
    • 任務
      • 嚴格的法規結構
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章光學臨床前影像市場：依產品類型

  • 介紹
  • 消耗品
  • 裝置
    • 生物發光
      • 腔腸素
      • 螢光素
      • 螢光素原
    • 螢光
      • 綠色螢光蛋白
      • 紅外線染料
      • 紅色螢光蛋白
  • 軟體

第7章光學臨床前影像市場：依最終用途分類

  • 介紹
  • 製藥和生物技術公司
  • 研究所

第8章美洲光學臨床前影像市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太光學臨床前影像市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲光學臨床前影像市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies Inc.
  • Analytik Jena GmbH
  • Angstrom Advanced Inc
  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co.KG
  • Bruker Corporation
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • INDEC Systems, Inc.
  • LI-COR, Inc.
  • Magnetic Insight, Inc.
  • MBF Bioscience
  • Mediso Ltd.
  • Milabs BV
  • Miltenyi BIoTec BV & Co. KG
Product Code: MRR-7C5681F867B6

The Optical Preclinical Imaging Market was valued at USD 1.32 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 14.39%, to USD 3.39 billion by 2030.

The optical preclinical imaging market is focused on non-invasive visualization techniques used in laboratory research stages to monitor disease progression, drug efficacy, and biological processes in live animals, primarily rodents. This niche market is necessary for translational research, where insights from animal models contribute to the understanding and treatment of human diseases, making it indispensable in drug development and biomedicine. Applications extend across oncology, neurology, cardiology, and stem cell research, with its usage vital in academia, pharmaceutical, and biotechnology sectors for preclinical scopes. Key growth drivers include technological advancements in imaging techniques, such as fluorescence and bioluminescence, which enhance resolution and sensitivity. The increasing prevalence of chronic diseases, escalating R&D expenditures, and the push for more ethical alternatives to human and animal testing further fuel market expansion. Emerging opportunities lie in integrating artificial intelligence for enhanced image analysis, miniaturization, and the development of multimodal imaging systems that provide comprehensive insights across biological systems. However, the market faces limitations in high equipment costs, complex regulatory landscapes, and the demand for skilled personnel, which can act as barriers for new entrants. Compliance with evolving ethical standards and the validation of animal models to accurately mimic human diseases remain challenging. Future innovation could focus on reducing the invasiveness and cost of imaging technologies, broadening their accessibility. Companies are recommended to invest in partnerships with academic and research institutions to leverage cutting-edge advancements and to pursue markets in emerging regions where research infrastructure is growing. The nature of the optical preclinical imaging market is dynamic, driven by rapid technological innovation and a strong intersection with various life sciences disciplines, offering vast potential for growth but demanding agility and forward-thinking strategies from stakeholders.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 3.39 billion
CAGR (%) 14.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optical Preclinical Imaging Market

The Optical Preclinical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased use of preclinical imaging in different sectors
    • Growing number of clinical research organizations (CROs) and pharmaceutical companies
    • Increasing applications in life science and cosmetic
  • Market Restraints
    • High installation and operational costs
  • Market Opportunities
    • Technological advancement in molecular imaging
    • Rising funding from public-private partnership to support pre clinical researches
  • Market Challenges
    • Strict regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Optical Preclinical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optical Preclinical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optical Preclinical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optical Preclinical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optical Preclinical Imaging Market

A detailed market share analysis in the Optical Preclinical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optical Preclinical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optical Preclinical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optical Preclinical Imaging Market

A strategic analysis of the Optical Preclinical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Analytik Jena GmbH, Angstrom Advanced Inc, Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG, Bruker Corporation, FUJIFILM Holdings Corporation, General Electric Company, INDEC Systems, Inc., LI-COR, Inc., Magnetic Insight, Inc., MBF Bioscience, Mediso Ltd., Milabs B.V., and Miltenyi Biotec B.V. & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Optical Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Consumables, Device, and Software. The Device is further studied across Bioluminescence and Fluorescence. The Bioluminescence is further studied across Coelenterazine, Luciferins, and Proluciferins. The Fluorescence is further studied across Green Fluorescent Proteins, Infrared Dyes, and Red Fluorescent Proteins.
  • Based on End-Use, market is studied across Pharma & Biotech Companies and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased use of preclinical imaging in different sectors
      • 5.1.1.2. Growing number of clinical research organizations (CROs) and pharmaceutical companies
      • 5.1.1.3. Increasing applications in life science and cosmetic
    • 5.1.2. Restraints
      • 5.1.2.1. High installation and operational costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in molecular imaging
      • 5.1.3.2. Rising funding from public-private partnership to support pre clinical researches
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Optical Preclinical Imaging Market, by Product Type

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Device
    • 6.3.1. Bioluminescence
      • 6.3.1.1. Coelenterazine
      • 6.3.1.2. Luciferins
      • 6.3.1.3. Proluciferins
    • 6.3.2. Fluorescence
      • 6.3.2.1. Green Fluorescent Proteins
      • 6.3.2.2. Infrared Dyes
      • 6.3.2.3. Red Fluorescent Proteins
  • 6.4. Software

7. Optical Preclinical Imaging Market, by End-Use

  • 7.1. Introduction
  • 7.2. Pharma & Biotech Companies
  • 7.3. Research Institutes

8. Americas Optical Preclinical Imaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Optical Preclinical Imaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Optical Preclinical Imaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies Inc.
  • 2. Analytik Jena GmbH
  • 3. Angstrom Advanced Inc
  • 4. Aspect Imaging Ltd.
  • 5. Berthold Technologies GmbH & Co.KG
  • 6. Bruker Corporation
  • 7. FUJIFILM Holdings Corporation
  • 8. General Electric Company
  • 9. INDEC Systems, Inc.
  • 10. LI-COR, Inc.
  • 11. Magnetic Insight, Inc.
  • 12. MBF Bioscience
  • 13. Mediso Ltd.
  • 14. Milabs B.V.
  • 15. Miltenyi Biotec B.V. & Co. KG

LIST OF FIGURES

  • FIGURE 1. OPTICAL PRECLINICAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPTICAL PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPTICAL PRECLINICAL IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COELENTERAZINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY LUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PROLUCIFERINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY GREEN FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY INFRARED DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RED FLUORESCENT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENCE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM OPTICAL PRECLINICAL IMAGING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. OPTICAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. OPTICAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023